e-learning
resources
Glasgow 2004
Monday 06.09.2004
COPD and lung cancer: genetics and pathogenesis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased propensity for apoptosis and decreased Bcl-2 in peripheral blood T-cells from COPD patients - effect of corticosteroids?
S. J. Hodge, G. L. Hodge, H. Mark, R. N. Paul (Adelaide, Australia)
Source:
Annual Congress 2004 - COPD and lung cancer: genetics and pathogenesis
Session:
COPD and lung cancer: genetics and pathogenesis
Session type:
Thematic Poster Session
Number:
2020
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. J. Hodge, G. L. Hodge, H. Mark, R. N. Paul (Adelaide, Australia). Increased propensity for apoptosis and decreased Bcl-2 in peripheral blood T-cells from COPD patients - effect of corticosteroids?. Eur Respir J 2004; 24: Suppl. 48, 2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Increased proportion of Fas positive T-cells in never smoking patients with COPD
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Studies on blood lymphocytes apoptosis in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Treatment of COPD exacerbations is able to influence the mononuclear cells level of the peripheral blood
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Formoterol enhances anti-inflammatory effects of corticosteroid in peripheral blood mononuclear cells from COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 215s
Year: 2006
Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Fas positive CD8+ lymphocytes in peripheral blood of patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Pi3kδ expression is increased in peripheral lung macrophages in COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Intracellular cytokines in blood T cells and monocytes in lung transplant patients - potential utility in monitoring immunosuppression protocols
Source: Eur Respir J 2004; 24: Suppl. 48, 452s
Year: 2004
Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytes
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
In vitro responses of peripheral blood mononuclear cells in severe asthma patient treated with Mepolizumab
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Cytokine releasing mucosa-homing T cells are increased in peripheral blood of pulmonary fibrosis patients
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy
Source: Eur Respir J, 59 (3) 2101798; 10.1183/13993003.01798-2021
Year: 2022
T-regulatory cells blood content in patients with asthma exacerbation
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Standard therapy increases the sensitivity of peripheral blood lymphocytes to glucocorticoids in cystic fibrosis but not in severe asthma
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking
Source: Eur Respir J 2007; 29: 42-50
Year: 2007
Rapid decline in lung function in COPD is associated with decreased CD25brightFoxP3 regulatory T cells in BAL
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019
Interleukin-10 expressing regulatory B cells are decreased in blood of smokers and COPD patients
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
The expression of CD39 mRNA is altered in peripheral blood of patients with allergic asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept